Genetic Disorders of Obesity Program Database
Launched by BAYLOR COLLEGE OF MEDICINE · Feb 27, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Genetic Disorders of Obesity Program Database is a clinical trial focused on understanding severe obesity in children that starts at an early age. The study aims to gather information about children who are struggling with obesity due to genetic factors. Researchers hope that by collecting this data, they can learn more about the causes and best ways to treat these conditions.
To be eligible for the trial, children must be at least 2 years old with a body mass index (BMI) greater than the 97th percentile, meaning they weigh more than 97% of children their age. For younger children under 2 years, they should have a weight-to-length ratio above the 95th percentile. There are no other specific exclusions, so many children with severe obesity may qualify. Participants in the study can expect to provide information about their health and may also undergo tests or assessments as part of the research. This study is currently recruiting participants of all genders, and it aims to improve our understanding of childhood obesity, which could lead to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • For individuals 2 years and older, BMI \> 97 percentile
- • For individuals \< 2 years old, weight-to-length ratio \> 95th percentile
- Exclusion Criteria:
- • No other exclusion criteria
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials